<h3>漲幅榜</h3>
<ul>
<li><strong>Agilon Health</strong> (NYSE: AGL) 的股價在週四的盤前交易中上漲了 55.6%，達到 $43.33。該公司的市值為 $4.639 億。該公司的第一季度財報於昨天發佈。</li>
<li><strong>Atara Biotherapeutics</strong> (NASDAQ: ATRA) 的股票上漲了 40.77%，達到 $7.25。其流通股的市場價值為 $4380 萬。</li>
<li><strong>Cross Country Healthcare</strong> (NASDAQ: CCRN) 的股票上漲了 29.08%，達到 $13.05。該公司的市值為 $3.255 億。根據新聞稿，第一季度財報今天發佈。</li>
<li><strong>Aspire Biopharma Holdings</strong> (NASDAQ: ASBP) 的股票上漲了 26.72%，達到 $0.24。</li>
<li><strong>Inovio Pharmaceuticals</strong> (NASDAQ: INO) 的股票上漲了 18.54%，達到 $1.47。該公司的市值為 $1.011 億。</li>
<li><strong>Ernexa Therapeutics</strong> (NASDAQ: ERNA) 的股價上漲了 16.55%，達到 $7.04。其流通股的市場價值為 $700 萬。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>enGene Therapeutics</strong> (NASDAQ: ENGN) 的股價在週四的盤前交易中下跌了 67.5%，達到 $2.88。該公司的市值為 $5.928 億。</li>
<li><strong>Entrada Therapeutics</strong> (NASDAQ: TRDA) 的股票下跌了 47.6%，達到 $8.4。其流通股的市場價值為 $6.222 億。</li>
<li><strong>Pharming</strong> (NASDAQ: PHAR) 的股價下跌了 19.62%，達到 $13.18。其流通股的市場價值為 $11 億。根據新聞，第一季度財報今天發佈。</li>
<li><strong>ADMA Biologics</strong> (NASDAQ: ADMA) 的股票下跌了 18.86%，達到 $8.18。其流通股的市場價值為 $23 億。該公司的第一季度財報於昨天發佈。</li>
<li><strong>Accuray</strong> (NASDAQ: ARAY) 的股價下跌了 14.3%，達到 $0.41。該公司的市值為 $5400 萬。該公司的第三季度財報於昨天發佈。</li>
<li><strong>Zoetis</strong> (NYSE: ZTS) 的股票下跌了 13.68%，達到 $96.01。該公司的市值為 $469 億。該公司的第一季度財報今天發佈。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>

TRDA

Atara生物治療

<p>在週四的盤前交易中，幾隻醫療保健股票經歷了顯著波動。Agilon Health (AGL) 上漲了 55.6%，達到 43.33 美元，而 Atara Biotherapeutics (ATRA) 上漲了 40.77%，達到 7.25 美元。Cross Country Healthcare (CCRN) 增加了 29.08%，達到 13.05 美元。相反，LosersenGene Therapeutics (ENGN) 下跌了 67.5%，至 2.88 美元，Entrada Therapeutics (TRDA) 下跌了 47.6%，至 8.4 美元。Pharming (PHAR) 和 ADMA Biologics (ADMA) 也分別下跌了 19.62% 和 18.86%。財報影響了這些股票的波動</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>漲幅榜</h3>
</div><ul>
<li><strong>Agilon Health</strong> (NYSE: AGL) shares moved upwards by 55.6% to $43.33 during Thursday's pre-market session. The company's market cap stands at $463.9 million. The company's, Q1 earnings came out yesterday.</li>
<li><strong>Atara Biotherapeutics</strong> (NASDAQ: ATRA) stock moved upwards by 40.77% to $7.25. The market value of their outstanding shares is at $43.8 million.</li>
<li><strong>Cross Country Healthcare</strong> (NASDAQ: CCRN) stock rose 29.08% to $13.05. The company's market cap stands at $325.5 million. As per the press release, Q1 earnings came out today.</li>
<li><strong>Aspire Biopharma Holdings</strong> (NASDAQ: ASBP) stock increased by 26.72% to $0.24.</li>
<li><strong>Inovio Pharmaceuticals</strong> (NASDAQ: INO) stock moved upwards by 18.54% to $1.47. The company's market cap stands at $101.1 million.</li>
<li><strong>Ernexa Therapeutics</strong> (NASDAQ: ERNA) shares moved upwards by 16.55% to $7.04. The market value of their outstanding shares is at $7.0 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Agilon Health</strong> (NYSE: AGL) 的股價在週四的盤前交易中上漲了 55.6%，達到 $43.33。該公司的市值為 $4.639 億。該公司的第一季度財報於昨天發佈。</li>
<li><strong>Atara Biotherapeutics</strong> (NASDAQ: ATRA) 的股票上漲了 40.77%，達到 $7.25。其流通股的市場價值為 $4380 萬。</li>
<li><strong>Cross Country Healthcare</strong> (NASDAQ: CCRN) 的股票上漲了 29.08%，達到 $13.05。該公司的市值為 $3.255 億。根據新聞稿，第一季度財報今天發佈。</li>
<li><strong>Aspire Biopharma Holdings</strong> (NASDAQ: ASBP) 的股票上漲了 26.72%，達到 $0.24。</li>
<li><strong>Inovio Pharmaceuticals</strong> (NASDAQ: INO) 的股票上漲了 18.54%，達到 $1.47。該公司的市值為 $1.011 億。</li>
<li><strong>Ernexa Therapeutics</strong> (NASDAQ: ERNA) 的股價上漲了 16.55%，達到 $7.04。其流通股的市場價值為 $700 萬。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>enGene Therapeutics</strong> (NASDAQ: ENGN) shares decreased by 67.5% to $2.88 during Thursday's pre-market session. The company's market cap stands at $592.8 million.</li>
<li><strong>Entrada Therapeutics</strong> (NASDAQ: TRDA) stock fell 47.6% to $8.4. The market value of their outstanding shares is at $622.2 million.</li>
<li><strong>Pharming</strong> (NASDAQ: PHAR) shares fell 19.62% to $13.18. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q1 earnings report came out today.</li>
<li><strong>ADMA Biologics</strong> (NASDAQ: ADMA) stock declined by 18.86% to $8.18. The market value of their outstanding shares is at $2.3 billion. The company's, Q1 earnings came out yesterday.</li>
<li><strong>Accuray</strong> (NASDAQ: ARAY) shares decreased by 14.3% to $0.41. The company's market cap stands at $54.0 million. The company's, Q3 earnings came out yesterday.</li>
<li><strong>Zoetis</strong> (NYSE: ZTS) stock declined by 13.68% to $96.01. The company's market cap stands at $46.9 billion. The company's, Q1 earnings came out today.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>enGene Therapeutics</strong> (NASDAQ: ENGN) 的股價在週四的盤前交易中下跌了 67.5%，達到 $2.88。該公司的市值為 $5.928 億。</li>
<li><strong>Entrada Therapeutics</strong> (NASDAQ: TRDA) 的股票下跌了 47.6%，達到 $8.4。其流通股的市場價值為 $6.222 億。</li>
<li><strong>Pharming</strong> (NASDAQ: PHAR) 的股價下跌了 19.62%，達到 $13.18。其流通股的市場價值為 $11 億。根據新聞，第一季度財報今天發佈。</li>
<li><strong>ADMA Biologics</strong> (NASDAQ: ADMA) 的股票下跌了 18.86%，達到 $8.18。其流通股的市場價值為 $23 億。該公司的第一季度財報於昨天發佈。</li>
<li><strong>Accuray</strong> (NASDAQ: ARAY) 的股價下跌了 14.3%，達到 $0.41。該公司的市值為 $5400 萬。該公司的第三季度財報於昨天發佈。</li>
<li><strong>Zoetis</strong> (NYSE: ZTS) 的股票下跌了 13.68%，達到 $96.01。該公司的市值為 $469 億。該公司的第一季度財報今天發佈。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>
</div>

12 只醫療保健股票在週四盤前交易時段的變動